Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization

Analytical Biochemistry

Volumn 310, Issue 2, 2002, Pages 199-207

  Osmond, Ronald I W ^a   Kett, Warren C ^a   Skett, Spencer E ^a   Coombe, Deirdre R ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Binding proteins; Heparin; Surface plasmon resonance

Indexed keywords

AMINES; CARBOXYLATION; PLASMONS; PROTEINS; SURFACE PLASMON RESONANCE;

BINDING ANALYSIS; BINDING CAPACITIES; BINDING PROTEINS; CARBOXYLATE GROUPS; HEPARIN; HEPARIN IMMOBILIZATION; HEPARIN-BINDING PROTEINS; SURFACE PLASMON RESONANCE BIOSENSOR;

POLYSACCHARIDES;

FIBROBLAST GROWTH FACTOR; HEPARIN; HEPARIN BINDING PROTEIN; PROTEIN; STREPTAVIDIN; URONIC ACID; ANTITHROMBIN III; AVIDIN; BIOTIN; GLUCOSAMINE; LACTOFERRIN; THROMBIN;

ARTICLE; BINDING AFFINITY; BIOSENSOR; BIOTINYLATION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; SENSOR; SURFACE PLASMON RESONANCE; ANIMAL; BINDING COMPETITION; CHEMISTRY; COMPARATIVE STUDY; GENETIC PROCEDURES; HUMAN; INSTRUMENTATION; METABOLISM; METHODOLOGY; PROTEIN BINDING; SURFACE PROPERTY; SWINE;

ANIMALS; ANTITHROMBIN III; AVIDIN; BINDING, COMPETITIVE; BIOSENSING TECHNIQUES; BIOTIN; GLUCOSAMINE; HEPARIN; HUMANS; LACTOFERRIN; PROTEIN BINDING; STREPTAVIDIN; SURFACE PLASMON RESONANCE; SURFACE PROPERTIES; SWINE; THROMBIN; URONIC ACIDS;

EID: 0037112671     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(02)00396-2     Document Type: Article

References (29)

1. B. Mulloy, R. Linhardt, Order out of complexity - Protein structures that interact with heparin, Curr. Opin. Struct. Biol. 11 (2001) 623-628.
2. J. Turnbull, A. Powell, S. Guimond, Heparan sulfate: Decoding a dynamic multifunctional cell regulator, Trends Cell. Biol. 11 (2001) 75-82.
3. R. Sasisekharan, G. Venkataraman, Heparin and heparan sulfate: Biosynthesis, structure, and function, Curr. Opin. Chem. Biol. 4 (2000) 626-631.
4. H.B. Nader, C.P. Dietrich, in: D.A. Lane, U. Lindahl (Eds.), Heparin: Chemical and Biological Properties, Clinical Applications, CRC Press, Boca Raton, FL, 1989, pp. 81-96.
5. S. Knox, C. Merry, S. Stringer, J. Melrose, J. Whitelock, Not all perlecans are created equal. Interactions with fibroblast growth factor (FGF) 2 and FGF receptors, J. Biol. Chem. 277 (2002) 14657-14665.
6. H.E. Conrad, Heparin-Binding Proteins, Academic Press, San Diego, 1998.
7. F. Zhang, M. Fath, R. Marks, R.J. Linhardt, A highly stable covalent conjugated heparin biochip for heparin-protein interaction studies, Anal. Biochem. 304 (2002) 271-273.
8. U. Friedrich, A.M. Blom, B. Dahlback, B.O. Villoutreix, Structural and energetic characteristics of the heparin-binding site in antithrombotic protein c, J. Biol. Chem. 276 (2001) 24122-24128.
9. M. Rusnati, C. Urbinati, A. Caputo, L. Possati, H. Lortat-Jacob, M. Giacca, D. Ribatti, M. Presta, Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat, J. Biol. Chem. 276 (2001) 22420-22425.
10. E. Bengtsson, A. Aspberg, D. Heinegård, Y. Sommarin, D. Spillman, The amino-terminal part of PRELP binds to heparin and heparan sulfate, J. Biol. Chem. 275 (2000) 40695-40702.
11. S.L. Carney, in: M.F. Chapli, J.F. Kennedy (Eds.), Carbohydrate Analysis. A Practical Approach, IRL Press, Washington, DC, 1994, pp. 97-141.
12. C.G. Goodno, H.E. Swaisgood, G.L. Catignani, A fluorimetric assay for available lysine in proteins, Anal. Biochem. 115 (1981) 203-211.
13. T. Toida, H. Yoshida, H. Toyoda, I. Koshiishi, T. Imanari, R.E. Hileman, J.R. Fromm, R.J. Linhardt, Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species, Biochem. J. 322 (1997) 499-506.
14. J. Liu, U.R. Desai, X.J. Han, T. Toida, R.J. Linhardt, Strategy for the sequence analysis of heparin, Glycobiology 5 (1995) 765-774.
15. G. Pejler, Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: Characterization of the binding of heparin to lactoferrin, Biochem. J. 320 (1996) 897-903.
16. J.E. Turnbull, D.G. Fernig, Y. Ke, M.C. Wilkinson, J.T. Gallagher, Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate, J. Biol. Chem. 267 (1992) 10337-10341.
17. O. Ostrovsky, B. Berman, J.T. Gallagher, B. Mulloy, D.G. Fernig, M. Delehedde, D. Ron, Differential effects of heparin saccharides on the formation of specific growth factor (FGF) and FGF receptor complexes, J. Biol. Chem. 277 (2002) 2444-2453.
18. M. Maccarana, B. Casu, U. Lindahl, Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor, J. Biol. Chem. 268 (1993) 23898-23905.
19. U. Lindahl, G. Bäckström, L. Thundberg, The antithrombin binding sequence in heparin, J. Biol. Chem. 258 (1983) 9826-9830.
20. M.J. Griffith, H.S. Kingdon, R.L. Lundblad, Fractionation of heparin by affinity chromatography on covalently-bound human α-thrombin, Biochem. Biophys. Res. Commun. 83 (1978) 1198-1205.
21. R.E. Jordan, G.M. Oosta, W.T. Gardner, R.D. Rosenberg, The binding of low molecular weight heparin to hemostatic enzymes, J. Biol. Chem. 255 (1980) 10073-10080.
22. H. Mach, D.B. Volkin, C.J. Burke, C.R. Middaugh, Nature of the interaction of heparin with acidic fibroblast growth factor, Biochem. 32 (1993) 5480-5489.
23. U. Lindahl, J.A. Cifonelli, B. Lindahl, L. Rodén, The role of serine in the linkage of heparin to protein, J. Biol. Chem. 240 (1965) 2817-2820.
24. U. Lindahl, L. Rodén, The role of galactose and xylose in the linkage of heparin to protein, J. Biol. Chem. 240 (1965) 2821-2826.
25. B. Mulloy, M.J. Forster, Conformation and dynamics of heparin and heparan sulfate, Glycobiology 10 (2000) 1147-1156.
26. L. Pellegrini, D.F. Burke, F. von Delft, B. Mulloy, T.L. Blundell, Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin, Nature 407 (2000) 1029-1034.
27. L. Jin, J.P. Abrahams, R. Skinner, M. Petitou, R.N. Pike, R.W. Carroll, The anticoagulant activation of antithrombin by heparin, Proc. Natl. Acad. Sci. USA 94 (1997) 14683-14688.
28. S. Faham, R.E. Hileman, J.R. Fromm, R.J. Linhardt, D.C. Rees, Heparin structure and interactions with basic fibroblast growth factor, Science 271 (1996) 1116-1120.
29. J.S. Pieper, T. Hafmans, J.H. Veerkamp, T.H. van Kuppevelt, Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects, Biomaterials 21 (2000) 581-592.